Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9)

被引:992
作者
Van den Steen, PE
Dubois, B
Nelissen, I
Rudd, PM
Dwek, RA
Opdenakker, G
机构
[1] Univ Louvain, Rega Inst Med Res, B-3000 Louvain, Belgium
[2] Univ Oxford, Glycobiol Inst, Oxford OX1 2JD, England
关键词
D O I
10.1080/10409230290771546
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The matrix metalloproteinases (MMPs) form an enzyme family of which gelatinase B (MMP-9) represents the largest and most complex member. We focus here on the biochemical properties, regulation, and functions of gelatinase B. The tight regulation of gelatinase B activity is highly complex and is established at five different levels. The transcription of the gelatinase B-gene depends on various cis-elements in its gene promotor and is induced or repressed by a large variety of soluble factors, including cytokines, growth factors, and hormones and by cellular contacts acting through specific signaling pathways. The specific regulation of its secretion occurs in cells storing gelatinase B in granules. After secretion, progelatinase B must be activated through an activation network. The enzyme activity is further regulated by inhibition and by other mechanisms, such as fine-tuning and stabilization by glycosylation. The ability of gelatinase B to degrade components of the extracellular matrix and to regulate the activity of a number of soluble proteins confers an important role in various physiological and pathological processes. These include reproduction, growth, development, inflammation, and vascular and proliferative diseases.
引用
收藏
页码:375 / 536
页数:162
相关论文
共 840 条
  • [1] Gelatinase B in proliferative vitreoretinal disorders
    Abu El-Asrar, AM
    Dralands, L
    Veckeneer, M
    Geboes, K
    Missotten, L
    Van Aelst, I
    Opdenakker, G
    [J]. AMERICAN JOURNAL OF OPHTHALMOLOGY, 1998, 125 (06) : 844 - 851
  • [2] Expression of gelatinase B in trachomatous conjunctivitis
    Abu El-Asrar, AM
    Geboes, K
    Al-Kharashi, SA
    Al-Mosallam, AA
    Missotten, L
    Paemen, L
    Opdenakker, G
    [J]. BRITISH JOURNAL OF OPHTHALMOLOGY, 2000, 84 (01) : 85 - 91
  • [3] AGARWAL C, 1994, CANCER RES, V54, P943
  • [4] GELATINASE ACTIVITY DURING WOUND-HEALING
    AGREN, MS
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 1994, 131 (05) : 634 - 640
  • [5] Agrez M, 1999, INT J CANCER, V81, P90, DOI 10.1002/(SICI)1097-0215(19990331)81:1<90::AID-IJC16>3.0.CO
  • [6] 2-K
  • [7] Association between αvβ6 integrin expression, elevated p42/44 kDa MAPK, and plasminogen-dependent matrix degradation in ovarian cancer
    Ahmed, N
    Pansino, F
    Baker, M
    Rice, G
    Quinn, M
    [J]. JOURNAL OF CELLULAR BIOCHEMISTRY, 2002, 84 (04) : 675 - 686
  • [8] Overexpression of αvβ6 integrin in serous epithelial ovarian cancer regulates extracellular matrix degradation via the plasminogen activation cascade
    Ahmed, N
    Pansino, F
    Clyde, R
    Murthi, P
    Quinn, MA
    Rice, GE
    Agrez, MV
    Mok, S
    Baker, MS
    [J]. CARCINOGENESIS, 2002, 23 (02) : 237 - 244
  • [9] Expression of matrix metalloproteinase 9 (96-kd gelatinase B) in human rheumatoid arthritis
    Ahrens, D
    Koch, AE
    Pope, RM
    SteinPicarella, M
    Niedbala, MJ
    [J]. ARTHRITIS AND RHEUMATISM, 1996, 39 (09): : 1576 - 1587
  • [10] INHIBITION OF INVASION, GELATINASE ACTIVITY, TUMOR TAKE AND METASTASIS OF MALIGNANT-CELLS BY N-ACETYLCYSTEINE
    ALBINI, A
    DAGOSTINI, F
    GIUNCIUGLIO, D
    PAGLIERI, I
    BALANSKY, R
    DEFLORA, S
    [J]. INTERNATIONAL JOURNAL OF CANCER, 1995, 61 (01) : 121 - 129